U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday ...

The lawsuit is one of many claims made nationwide that the over-the-counter heartburn drug Zantac and its generics have an ...

An 89-year-old woman is suing GSK and Boehringer Ingelheim, claiming Zantac caused her cancer. The companies deny the ...

An attorney for plaintiff Angela Valadez argued for a direct link between her cancer diagnosis and Zantac, which she took for ...

Henry Simmons, a former judge and managing partner at Clifford Law Offices, joins Lisa Dent to talk about the first-ever ...

Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing ...

Plaintiffs said the companies knew, or should have known, that ranitidine posed a cancer risk and that they failed to warn consumers. The U.S. Food and Drug Administration asked manufacturers to ...

Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to ...

Sanofi will pay more than US$100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn ...

Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug ... that ranitidine posed a cancer risk and that they failed to warn ...